Mitokinin

PINK1-targeted therapies for mitochondria-associated diseases (familial form of Parkinson's Disease)

placeNew York City, New York, United States calendar_todayFounded 2012 groups19 employees language mitokinin.com

Innovation

11 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,563 times.

YearFilings
20141
20152
20162
20171
20182
20192
20205
20215
20226
20235
20247
20253

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Accelerator & incubator117%
Other / undisclosed350%
Coming soon